Ostéoporose chez le sujet âgé

Presse Medicale - Tập 35 - Trang 1547-1556 - 2006
Frédérique Retornaz1,2, Gustavo Duque1,3
1Division de gériatrie, Université McGill, Hôpital Général Juif, Montréal, Québec, Canada
2Service de médecine interne et gériatrie, Centre hospitalier régional et universitaire de Marseille, Hôpital Sainte Marguerite, Marseille (13)
3Centre de recherche Bloomfield, Institut Lady Davis, Université McGill, Montréal, Québec, Canada

Tài liệu tham khảo

Becker, 2006, Characteristics of elderly patients admitted to an urban tertiary care hospital with osteoporotic fractures: correlations with risk factors, fracture type, gender and ethnicity, Osteoporos Int, 17, 410, 10.1007/s00198-005-0001-1 World Health Organisation Assessment of fracture risk and its applications to screening for postmenopausal osteoporosis. WHO technical report series, N843, Geneva: Switzerland World Health Organisation, 1994. Ralston, 2005, Genetic determinants of osteoporosis, Curr Opin Rheumatol, 17, 475, 10.1097/01.bor.0000166385.62851.92 Eckstein, 2004, Determinants and heterogeneity of mechanical competence throughout the thoracolumbar spine of elderly women and men, Bone, 35, 364, 10.1016/j.bone.2004.04.008 Johnell, 2005, Predictive value of BMD for hip and other fractures, J Bone Miner Res, 20, 1185, 10.1359/JBMR.050304 Raisz, 2005, Pathogenesis of osteoporosis: concepts, conflicts, and prospects, J Clin Invest, 115, 3318, 10.1172/JCI27071 Raisz, 2003, Pathogenesis of osteoporosis, Endocrinol Metab Clin North Am, 32, 15, 10.1016/S0889-8529(02)00055-5 Priestwood and Duque. Chapter on osteoporosis. In: Hazzard textbook of medicine 5th edition, chapter 76. Cummings, 2002, Epidemiology and outcomes of osteoporotic fractures, Lancet, 359, 1761, 10.1016/S0140-6736(02)08657-9 Dargent-Molina, 2004, Epidemiology and risk factors for osteoporosis, Rev Med Interne, 25, S517, 10.1016/S0248-8663(04)80049-3 Blain, 2004, Osteoporosis in men: epidemiology, physiopathology, diagnosis, prevention and treatment, Rev Med Interne, 25, S552, 10.1016/S0248-8663(04)80054-7 Wallace, 2000, Bone health in nursing home residents, JAMA, 284, 1018, 10.1001/jama.284.8.1018 Siris, 2006, The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA), Osteoporos Int, 17, 565, 10.1007/s00198-005-0027-4 Johnell, 2005, Epidemiology of osteoporotic fractures, Osteoporos Int, 16, S3, 10.1007/s00198-004-1702-6 Klotzbuecher, 2000, Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis, J Bone Miner Res, 15, 721, 10.1359/jbmr.2000.15.4.721 Baudoin, 1996, Hip fractures in France: the magnitude and perspective of the problem, Osteoporos Int, 6, 1, 10.1007/BF01623756 Osteoporosis in Europe: indicators of progress. Report of International Osteoporosis Foundation February 2005. http://www.osteofound.org/advocacy_policy/ eu_policy_project/pdf/indicators_of_progress.pdf. Consulté le 14.02.06. Maravic, 2005, Incidence and cost of osteoporotic fractures in France during 2001 A methodological approach by the national hospital database, Osteoporos Int, 16, 1475, 10.1007/s00198-005-2031-0 Fontana, 2001, 17 No authors listed. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002, 17: 716-24. Grados, 2004, Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study, Bone, 34, 362, 10.1016/j.bone.2003.11.008 Nevitt, 1993, Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures, J Am Geriatr Soc, 41, 1226, 10.1111/j.1532-5415.1993.tb07307.x Kelsey, 1992, Risk factors for fractures of the distal forearm and proximal humerus, Am J Epidemiol, 135, 477, 10.1093/oxfordjournals.aje.a116314 Center, 1999, Mortality after all major types of osteoporotic fracture in men and women: an observational study, Lancet, 353, 878, 10.1016/S0140-6736(98)09075-8 Cooper, 1993, Population-based study of survival after osteoporotic fractures, Am J Epidemiol, 137, 1001, 10.1093/oxfordjournals.aje.a116756 Ishida, 2005, Factors affecting ambulatory status and survival of patients 90 years and older with hip fractures, Clin Orthop Relat Res, 208, 10.1097/01.blo.0000159156.40002.30 Ismail, 1998, Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS), Osteoporos Int, 8, 291, 10.1007/s001980050067 Hasserius, 2005, Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly--a 12- and 22-year follow-up of 257 patients, Calcif Tissue Int, 76, 235, 10.1007/s00223-004-2222-2 Melton, 2000, Excess mortality following vertebral fracture, J Am Geriatr Soc, 48, 338, 10.1111/j.1532-5415.2000.tb02658.x Kado, 2003, Incident vertebral fractures and mortality in older women: a prospective study, Osteoporos Int, 14, 589, 10.1007/s00198-003-1412-5 Fink, 2003, Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT), Osteoporos Int, 14, 69, 10.1007/s00198-002-1314-y Cooper, 1992, Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota 1985-1989, J Bone Miner Res, 7, 221, 10.1002/jbmr.5650070214 Nevitt, 1998, The association of radiographically detected vertebral fractures with back pain and function: a prospective study, Ann Intern Med, 128, 793, 10.7326/0003-4819-128-10-199805150-00001 L’ostéoporose dans la Communauté Européenne: Plan d’Action-Rapport sur les étapes clés d’une Europe exempte de fractures par fragilité. Novembre 2003 http://www.osteofound.org/publications/eu_reports.html, consultéle 14/02/06. Cooper, 1992, Hip fractures in the elderly: a world-wide projection, Osteoporos Int, 2, 285, 10.1007/BF01623184 De Laet, 1999, Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam study, Osteoporos Int, 10, 66, 10.1007/s001980050196 Kanis, 2002, Diagnosis of osteoporosis and assessment of fracture risk, Lancet, 359, 1929, 10.1016/S0140-6736(02)08761-5 Delaney, 2006, Strategies for the prevention and treatment of osteoporosis during early postmenopause, Am J Obstet Gynecol, 194, S12, 10.1016/j.ajog.2005.08.049 Gregg, 2000, Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence, J Am Geriatr Soc, 48, 883, 10.1111/j.1532-5415.2000.tb06884.x Dargent-Molina, 1996, Fall-related factors and risk of hip fracture: the EPIDOS prospective study, Lancet, 348, 145, 10.1016/S0140-6736(96)01440-7 Retornaz, 2005, La réduction du risque de chute, Le rhumatologue, 23, 45 Taylor, 2004, Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures, J Am Geriatr Soc, 52, 1479, 10.1111/j.1532-5415.2004.52410.x Montero-Odasso, 2005, Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone, Mol Aspects Med, 26, 203, 10.1016/j.mam.2005.01.005 Dargent-Molina, 2005, Identification of women at increased risk of osteoporosis: No need to use different screening tools at different ages, Maturitas, 6, 55 Saliba, 2005, Quality indicators for the management of medical conditions in nursing home residents, J Am Med Dir Assoc, 6, S36, 10.1016/j.jamda.2005.03.022 Retornaz, 2004, Secondary osteoporosis and internal medicine, Rev Med Interne, 25, S543, 10.1016/S0248-8663(04)80053-5 Kannus, 2005, Prevention of falls and consequent injuries in elderly people, Lancet, 366, 1885, 10.1016/S0140-6736(05)67604-0 Tinetti, 2003, Clinical practice Preventing falls in elderly persons, N Engl J Med, 348, 42, 10.1056/NEJMcp020719 Liu-Ambrose, 2005, The beneficial effects of group-based exercises on fall risk profile and physical activity persist 1 year postintervention in older women with low bone mass: follow-up after withdrawal of exercise, J Am Geriatr Soc, 53, 1767, 10.1111/j.1532-5415.2005.53525.x Healey, 2004, Using targeted risk factor reduction to prevent falls in older in-patients: a randomised controlled trial, Age Ageing, 33, 390, 10.1093/ageing/afh130 Haines, 2004, Effectiveness of targeted falls prevention programme in subacute hospital setting: randomised controlled trial, BMJ, 328, 676, 10.1136/bmj.328.7441.676 Schoor, 2003, The Amsterdam Hip Protector Study: compliance and determinants of compliance, Osteoporos Int, 14, 353, 10.1007/s00198-003-1382-7 Sawka, 2005, Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials, Osteoporos Int, 16, 1461, 10.1007/s00198-005-1932-2 Parker, 2006, Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review, BMJ, 332, 571, 10.1136/bmj.38753.375324.7C Rooij, 2006, Hip protectors to prevent femoral fracture, BMJ, 332, 559, 10.1136/bmj.332.7541.559 Gerdhem, 2005, Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women, Osteoporos Int, 16, 1425, 10.1007/s00198-005-1860-1 Bischoff-Ferrari, 2005, Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials, JAMA, 293, 2257, 10.1001/jama.293.18.2257 Lips, 2001, Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications, Endocr Rev, 22, 477, 10.1210/er.22.4.477 Duque, 2005, 1, 25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6), Am J Physiol Endocrinol Metab, 288, E723, 10.1152/ajpendo.00180.2004 Duque, 2004, Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity, Biogerontology, 5, 421, 10.1007/s10522-004-3192-5 Bischoff-Ferrari, 2004, Effect of Vitamin D on falls: a meta-analysis, JAMA, 291, 1999, 10.1001/jama.291.16.1999 Venning, 2005, Recent developments in vitamin D deficiency and muscle weakness among elderly people, BMJ, 330, 524, 10.1136/bmj.330.7490.524 Dhesi, 2004, Vitamin D supplementation improves neuromuscular function in older people who fall, Age Ageing, 33, 589, 10.1093/ageing/afh209 Bischoff-Ferrari, 2004, Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y, Am J Clin Nutr, 80, 752, 10.1093/ajcn/80.3.752 Ness, 2005, Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial, J Gerontol A Biol Sci Med Sci, 60, 460, 10.1093/gerona/60.4.460 Meier, 2005, Endocrine regulation of bone turnover in men, Clin Endocrinol (Oxf), 63, 603, 10.1111/j.1365-2265.2005.02333.x Simon, 2005, Osteoporosis, Clin Geriatr Med, 21, 603, 10.1016/j.cger.2005.02.002 Seeman, 2004, Estrogen, androgen, and the pathogenesis of bone fragility in women and men, Curr Osteoporos Rep, 2, 90, 10.1007/s11914-004-0016-0 Epstein, 2005, Biological properties and mechanism of action of ibandronate: application to the treatment of osteoporosis, Bone, 37, 433, 10.1016/j.bone.2005.05.007 Boonen, 2004, Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old, J Am Geriatr Soc, 52, 1832, 10.1111/j.1532-5415.2004.52506.x Hochberg, 2005, Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures, J Bone Miner Res, 20, 971, 10.1359/JBMR.050104 Mc Clung, 2001, N Engl J Med, 344, 333, 10.1056/NEJM200102013440503 Miller, 2005, Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials, J Bone Miner Res, 20, 2105, 10.1359/JBMR.050817 Ettinger, 1998, Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis, Am J Manag Care, 4, 1377 Tashjian, 2006, Teriparatide human PTH(1-34): 2 5 years of experience on the use and safety of the drug for the treatment of osteoporosis, J Bone Miner Res, 21, 354, 10.1359/JBMR.051023 Traitement médicamenteux de l’ostéoporose post-ménopausique. Recommandations de l’Agence française de sécurité des produits sanitaires AFSSAPS, Actualisation 2006, http://www.afssaps.sante.fr. Roux, 2006, Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors, J Bone Miner Res, 21, 536, 10.1359/jbmr.060101 Reginster, 2005, Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study, J Clin Endocrinol Metab, 90, 2816, 10.1210/jc.2004-1774